Biological Significance of Proliferation, Apoptosis, Cytokines, and Monocyte/Macrophage Cells in Bone Marrow Biopsies of 145 Patients With Myelodysplastic Syndrome-Reference-Cited by-同舟云学术

Biological Significance of Proliferation, Apoptosis, Cytokines, and Monocyte/Macrophage Cells in Bone Marrow Biopsies of 145 Patients With Myelodysplastic Syndrome

Published:2002-04 Issue:3 Volume:75 Page:289-297
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Allampallam Krishnan,Shetty Vilasini,Mundle Suneel,Dutt Diya,Kravitz Howard,Reddy Poluru L.,Alvi Sairah,Galili Naomi,Saberwal Gurveen S.,Anthwal Shalini,Shaikh Maliha W.,York Aaron,Raza Azra

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/article/10.1007/BF02982044/fulltext.html

Reference36 articles.

1. Iverson PO. Blood flow to the hematopoietic bone marrow.Acta Physiol Scand. 1997;159:269–276.

2. Wickramasinghe SN.Blood and Bone Marrow. 3rd ed. London, England: Churchill Livingstone; 1986.

3. San Miguel JF, Sanz GF, Vellaspi T, Canizo MC, Sanz MA. Myelodysplastic syndromes.Crit Rev Oncol Hematol. 1996;23:57–93.

4. Resegotti L. The nature and natural history of myelodysplasia.Haematologica. 1993;5:191–204.

5. Raza A, Gezer S, Mundle S, Gao XZ, et al. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes.Blood. 1995;86:268–276.

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elesclomol-copper synergizes with imidazole ketone erastin by promoting cuproptosis and ferroptosis in myelodysplastic syndromes;Biomedicine & Pharmacotherapy;2024-06

2. Immune‐monitoring of myelodysplastic neoplasms: Recommendations from the i4MDS consortium;HemaSphere;2024-05

3. p53 biology and reactivation for improved therapy in MDS and AML;Biomarker Research;2024-03-13

4. Diagnosis and Treatment of Myelodysplastic Syndromes;JAMA;2022-09-06

5. Immunodepletion of MDSC by AMV564, a novel bivalent, bispecific CD33/CD3 T cell engager, ex vivo in MDS and melanoma;Molecular Therapy;2022-06